Koers Cerenis Therapeutics Holding Euronext Paris
Aandelen
FR0012616852
Biotechnologie & Medisch Onderzoek
Omzet 2023 | 4,6 mln. 4,92 mln. | Omzet 2024 * | 4,6 mln. 4,92 mln. | Marktkapitalisatie | 32,98 mln. 35,26 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -3 mln. -3,21 mln. | Nettowinst (verlies) 2024 * | -6 mln. -6,42 mln. | EV/omzet 2023 | 9,02 x |
Nettoliquiditeiten 2023 * | 100K 107K | Nettoliquiditeiten 2024 * | 3,4 mln. 3,64 mln. | EV/omzet 2024 * | 6,43 x |
K/w-verhouding 2023 * |
-7,31
x | K/w-verhouding 2024 * |
-6,83
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 77,63% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 01-01-07 |
Director of Finance/CFO | - | 01-05-08 | |
Renee Benghozi
CTO | Chief Tech/Sci/R&D Officer | - | 09-02-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Olivier Martinez
BRD | Director/Board Member | 54 | - |
Christian Chavy
BRD | Director/Board Member | 75 | 06-02-15 |
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 01-01-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |